IgE‐based immunotherapy of cancer: challenges and chances
Passive immunotherapy with monoclonal antibodies is an indispensable cornerstone of clinical oncology. Notably, all FDA‐approved antibodies comprise the IgG class, although numerous research articles proposed monoclonal antibodies of the IgM, IgG, IgA and IgE classes directed specifically against tu...
Saved in:
Published in | Allergy (Copenhagen) Vol. 69; no. 2; pp. 137 - 149 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Denmark
Blackwell Publishing Ltd
01.02.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!